Items where authors include "Chhetri, S.K."
Article
Chataway, J., Williams, T., Blackstone, J. et al. (135 more authors) (2025) Effect of repurposed simvastatin on disability progression in secondary progressive multiple sclerosis (MS-STAT2): a phase 3, randomised, double-blind, placebo-controlled trial. The Lancet, 406 (10512). pp. 1611-1624. ISSN 0140-6736
Young, C.A. orcid.org/0000-0003-1745-7720, Chaouch, A., Mcdermott, C.J. orcid.org/0000-0002-1269-9053 et al. (8 more authors) (2025) Fatigue in amyotrophic lateral sclerosis/motor neuron disease: prevalence, influences and trajectories. Amyotrophic lateral sclerosis and frontotemporal degeneration. ISSN 2167-8421
Young, C.A. orcid.org/0000-0003-1745-7720, Chaouch, A., Mcdermott, C.J. orcid.org/0000-0002-1269-9053 et al. (6 more authors) (2025) Patient reported outcome measures require scale metrification and quantified precision: evidence from the assessment of breathlessness in people with ALS/MND. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. ISSN 2167-8421
Boddy, S.L., Simpson, R.M. orcid.org/0000-0003-1677-5938, Walters, S.J. et al. (38 more authors) (2025) Further development of a patient-reported outcome measure to assess the impact of oral secretion problems in people living with MND. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 26 (5-6). pp. 507-515. ISSN 2167-8421
Young, C.A. orcid.org/0000-0003-1745-7720, Chaouch, A., Mcdermott, C.J. orcid.org/0000-0002-1269-9053 et al. (12 more authors) (2025) Determinants and progression of stigma in amyotrophic lateral sclerosis/motor neuron disease. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 26 (3-4). pp. 192-202. ISSN 2167-8421
Young, C.A. orcid.org/0000-0003-1745-7720, Rog, D.J., Sharrack, B. et al. (6 more authors) (2024) Physical and psychological aspects of multiple sclerosis: revisiting the Multiple Sclerosis Impact Scale (MSIS-29). Multiple Sclerosis Journal, 30 (13). pp. 1630-1641. ISSN 1352-4585
Young, C.A. orcid.org/0000-0003-1745-7720, Chaouch, A., Mcdermott, C.J. orcid.org/0000-0002-1269-9053 et al. (6 more authors) (2024) Improving the measurement properties of the amyotrophic lateral sclerosis functional rating scale-revised (ALSFRS-R): deriving a valid measurement total for the calculation of change. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 25 (3-4). pp. 400-409. ISSN 2167-8421
Young, C.A. orcid.org/0000-0003-1745-7720, Chaouch, A., Mcdermott, C.J. orcid.org/0000-0002-1269-9053 et al. (10 more authors) (2024) Dyspnea (breathlessness) in amyotrophic lateral sclerosis/motor neuron disease: prevalence, progression, severity, and correlates. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. pp. 1-11. ISSN 2167-8421
Rawlinson, C., Gould, R.L., McDermott, C.J. orcid.org/0000-0002-1269-9053 et al. (27 more authors) (2024) Experiences of acceptance and commitment therapy for people living with motor neuron disease (MND): a qualitative study from the perspective of people living with MND and therapists. The Cognitive Behaviour Therapist, 17. e36. ISSN 1754-470X
Lombardo, F.L. orcid.org/0000-0001-6183-0735, Spila Alegiani, S., Mayer, F. et al. (93 more authors) (2023) A randomized double-blind clinical trial on safety and efficacy of tauroursodeoxycholic acid (TUDCA) as add-on treatment in patients affected by amyotrophic lateral sclerosis (ALS): the statistical analysis plan of TUDCA-ALS trial. Trials, 24 (1). 792. ISSN 1468-6708
Gould, R.L. orcid.org/0000-0001-9283-1626, Rawlinson, C., Thompson, B. et al. (43 more authors) (2023) Acceptance and commitment therapy for people living with motor neuron disease: an uncontrolled feasibility study. Pilot and Feasibility Studies, 9. 116. ISSN 2055-5784
Sproson, L., Lanfranchi, V. orcid.org/0000-0003-3148-2535, Collins, A. et al. (16 more authors) (2020) Fit for purpose? A cross-sectional study to evaluate the acceptability and usability of HeadUp, a novel neck support collar for neurological neck weakness. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 22 (1-2). pp. 38-45. ISSN 2167-8421
Up a level